Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Jul 20, 2020-- |!| Fort Madison
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Jul 20, 2020-- |!| Fort Madison